CellFE is a cell engineering startup that enables development and manufacturing of the new generation of medicines – cell therapies. CellFE has developed a unique microfluidic platform to solve one of the most pressing issues of therapeutic cell engineering –efficiently delivering gene-editing molecules into cells while preserving cell viability. CellFE’s technology:
• Enables development of previously inaccessible cell therapies by providing means for transporting hard-to-deliver molecules into the cells.
• Accelerates commercialization of existing cell therapies by significantly reducing cost, complexity, and processing time, while improving the efficacy and safety of the cell engineering process.
Company Details
- Employees
- 25
- Founded
- -
- Address
- Alameda, California 94502, Us
- Industry
- Biotechnology
- Website
- https://cellfebiotech.com
- Keywords
- Microfluidics, Biotech, Cell engineering, Crispr/Cas9, mRNA, Plasmid, Gene therapies, Viral vectors, Cell therapies, High throughput technology, Bioprocessing, Cancer therapies, Gene editing, Medical devices.
- HQ
- Alameda, California
Cellfe Questions
Cellfe's website is https://cellfebiotech.com
Cellfe's LinkedIn profile is https://www.linkedin.com/company/cellfe-biotech
Cellfe has
25 employees.
View email and phone details for 25
employees at Cellfe.
Cellfe's industry is
Biotechnology
Cellfe's top competitors are
Alaya.bio,
Kryptos Biotechnologies, Inc.,
Xcellbio,
Viralgen,
Century Therapeutics, Inc,
Meiragtx,
Axovia Therapeutics,
Levitasbio,
Virica Biotech,
Genprex, Inc..
Cellfe's categories are Biotechnology
Cellfe's founding year is 2018
